For the diagnosis of anti-MAG polyneuropathy the commercial ELISA manufacturer currently recommends a cut-off of 1000 Biihlmann Titer Units (BTU). We analyzed sera from 80 anti-MAG neuropathy patients and 383 controls (with other neuropathies or healthy controls) to assess the ELISA sensitivity and specificity at different thresholds. A better combination of sensitivity/specificity was found at a threshold > 1500 BTU than at > 1000 BTU. The best value of specificity was obtained at threshold > 7000 BTU. There was a diagnostic grey area between 1500 and 7000 BTU in which the clinical phenotypes as well as electrophysiological studies need to be carefully assessed particularly to differentiate CIDP and anti-MAG neuropathy.

Liberatore, G., Giannotta, C., Sajeev, B.p., Morenghi, E., Terenghi, F., Gallia, F., et al. (2020). Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy. JOURNAL OF NEUROIMMUNOLOGY, 345, 577288 [10.1016/j.jneuroim.2020.577288].

Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy

Marfia, Girolama Alessandra;
2020-08-01

Abstract

For the diagnosis of anti-MAG polyneuropathy the commercial ELISA manufacturer currently recommends a cut-off of 1000 Biihlmann Titer Units (BTU). We analyzed sera from 80 anti-MAG neuropathy patients and 383 controls (with other neuropathies or healthy controls) to assess the ELISA sensitivity and specificity at different thresholds. A better combination of sensitivity/specificity was found at a threshold > 1500 BTU than at > 1000 BTU. The best value of specificity was obtained at threshold > 7000 BTU. There was a diagnostic grey area between 1500 and 7000 BTU in which the clinical phenotypes as well as electrophysiological studies need to be carefully assessed particularly to differentiate CIDP and anti-MAG neuropathy.
ago-2020
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/26 - NEUROLOGIA
English
Con Impact Factor ISI
Anti-MAG polyneuropathy, chronic inflammatory demyelinating polyradiculoneuropathy
ELISA
Sensitivity
Specificity
Autoantibodies
Case-Control Studies
Enzyme-Linked Immunosorbent Assay
Humans
Myelin-Associated Glycoprotein
Polyneuropathies
Retrospective Studies
Liberatore, G., Giannotta, C., Sajeev, B.p., Morenghi, E., Terenghi, F., Gallia, F., et al. (2020). Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy. JOURNAL OF NEUROIMMUNOLOGY, 345, 577288 [10.1016/j.jneuroim.2020.577288].
Liberatore, G; Giannotta, C; Sajeev, Bp; Morenghi, E; Terenghi, F; Gallia, F; Doneddu, Pe; Manganelli, F; Cocito, D; Filosto, M; Antonini, G; Cosentino, G; Marfia, Ga; Clerici, Am; Lauria, G; Rosso, T; Cavaletti, G; Nobile-Orazio, E
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/257258
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 17
social impact